BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9217325)

  • 21. Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization.
    Crisp RJ; Knauer DJ; Knauer MF
    J Biol Chem; 2000 Jun; 275(26):19628-37. PubMed ID: 10867020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin modulation of intracellular calcium: a role for tyrosine phosphorylation.
    Miller BA; Bell LL; Lynch CJ; Cheung JY
    Cell Calcium; 1994 Dec; 16(6):481-90. PubMed ID: 7536133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a major cyclic AMP-dependent protein kinase A phosphorylation site within the cytoplasmic tail of the low-density lipoprotein receptor-related protein: implication for receptor-mediated endocytosis.
    Li Y; van Kerkhof P; Marzolo MP; Strous GJ; Bu G
    Mol Cell Biol; 2001 Feb; 21(4):1185-95. PubMed ID: 11158305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function.
    Susarla R; Watkinson JC; Eggo MC
    J Cell Physiol; 2007 Sep; 212(3):643-54. PubMed ID: 17458906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of urokinase-type-1 inhibitor complex endocytosis by phorbol esters in different cell lines is associated with differential regulation of alpha 2-macroglobulin receptor and urokinase receptor expression.
    Kjøller L; Simonsen AC; Ellgaard L; Andreasen PA
    Mol Cell Endocrinol; 1995 Apr; 109(2):209-17. PubMed ID: 7664984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor regulates cell surface plasminogen activator activity on human trophoblast cells.
    Zhang JC; Sakthivel R; Kniss D; Graham CH; Strickland DK; McCrae KR
    J Biol Chem; 1998 Nov; 273(48):32273-80. PubMed ID: 9822706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes.
    Nykjaer A; Conese M; Christensen EI; Olson D; Cremona O; Gliemann J; Blasi F
    EMBO J; 1997 May; 16(10):2610-20. PubMed ID: 9184208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand binding to macrophage scavenger receptor-A induces urokinase-type plasminogen activator expression by a protein kinase-dependent signaling pathway.
    Hsu HY; Hajjar DP; Khan KM; Falcone DJ
    J Biol Chem; 1998 Jan; 273(2):1240-6. PubMed ID: 9422792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of protein kinase modulators on transferrin receptor expression in human leukaemic HL-60 cells.
    Lok CN; Chan KF; Loh TT
    FEBS Lett; 1995 May; 365(2-3):137-40. PubMed ID: 7781766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells.
    Tang H; Kerins DM; Hao Q; Inagami T; Vaughan DE
    J Biol Chem; 1998 Jul; 273(29):18268-72. PubMed ID: 9660790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.
    Stefansson S; Kounnas MZ; Henkin J; Mallampalli RK; Chappell DA; Strickland DK; Argraves WS
    J Cell Sci; 1995 Jun; 108 ( Pt 6)():2361-8. PubMed ID: 7673355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
    J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
    Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretion of urokinase and metalloproteinase-9 induced by staurosporine is dependent on a tyrosine kinase pathway in mammary tumor cells.
    Aguirre Ghiso JA; Farías EF; Alonso DF; Bal de Kier Joffé E
    Int J Cancer; 1998 May; 76(3):362-7. PubMed ID: 9579573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.
    Sliva D; English D; Lyons D; Lloyd FP
    Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein kinase A regulates chondrogenesis of mesenchymal cells at the post-precartilage condensation stage via protein kinase C-alpha signaling.
    Yoon YM; Oh CD; Kang SS; Chun JS
    J Bone Miner Res; 2000 Nov; 15(11):2197-205. PubMed ID: 11092400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells.
    Vilhardt F; Nielsen M; Sandvig K; van Deurs B
    Mol Biol Cell; 1999 Jan; 10(1):179-95. PubMed ID: 9880335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue-specific expression of the relaxed conformation of plasminogen activator inhibitor-2 and low-density lipoprotein receptor-related protein in human term gestational tissues.
    Tsatas D; Baker MS; Rice GE
    J Histochem Cytochem; 1997 Dec; 45(12):1593-602. PubMed ID: 9389762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective asialoglycoprotein receptor endocytosis mediated by tyrosine kinase inhibitors. Requirement for a tyrosine in the receptor internalization signal.
    Fallon RJ; Danaher M; Saylors RL; Saxena A
    J Biol Chem; 1994 Apr; 269(15):11011-7. PubMed ID: 7512556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.
    Ippoliti R; Lendaro E; Benedetti PA; Torrisi MR; Belleudi F; Carpani D; Soria MR; Fabbrini MS
    FASEB J; 2000 Jul; 14(10):1335-44. PubMed ID: 10877826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.